Cyclosporine may reduce the risk of symptomatic COVID-19 in patients with systemic lupus erythematosus: a retrospective cohort study

ABSTRACT This study aimed to explore the effect of cyclosporine (CsA) on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in systemic lupus erythematosus (SLE) patients to provide a valuable reference for clinical treatment strategies in the context of the long-term risk of SAR...

全面介紹

書目詳細資料

Principais autores:	He-Jun Li, Shu-Huan Lin, Yan-Qing Wang, Ling Chen, Xiang-Xiong Zheng, Li-Xin Wei
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology 2024-11-01
叢編:	Microbiology Spectrum
主題:	systemic lupus erythematosus cyclosporine immunosuppressive therapy SARS-CoV-2 COVID-19
在線閱讀:	https://journals.asm.org/doi/10.1128/spectrum.01276-24
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!